13 Result(s)
within
Matthew R. Cooperberg
English
Urology
-
Article
Prostate cancer is not just a man’s concern — the use of PSA screening in transgender women
Transgender women remain at risk of prostate cancer and warrant consideration for PSA screening. However, current PSA reference ranges and guidelines are based on data from cisgender men. As these thresholds m...
-
Chapter
Nomograms and RALP Techniques for Management of ECE: Partial Nerve Sparing
Surgical dissection of neurovascular bundles is critical for improved functional outcomes when performing radical prostatectomy.
-
Chapter
Prostate Cancer Markers
Diagnostic biomarkers derived from blood, urine, or prostate tissue provide additional information beyond clinical calculators to determine the risk of detecting high-grade prostate cancer. Once diagnosed, m...
-
Article
Epidemiology of prostate cancer
-
Article
Why the prostate arm of the PLCO trial failed and what it has taught us
Given a recent update from the PLCO trial reporting that over 90% of men in the 'usual care' arm underwent some degree of PSA testing, the PLCO can no longer accurately be called a trial of screening versus no...
-
Article
Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy
To investigate variation in the International Prostate Symptom Score (IPSS) in men following prostate brachytherapy.
-
Article
Implications of the New AUA Guidelines on Prostate Cancer Detection in the U.S.
In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a blanket “D” recommendation against all prostate-specific antigen (PSA)-based early detection efforts for prostate cancer, reflecting critical ...
-
Article
Risk-Based Prostate Cancer Screening: Who and How?
The purpose of this review is to identify clinical risk factors for prostate cancer and to assess the utility and limitations of our current tools for prostate cancer screening. Prostate-specific antigen is th...
-
Article
New types of radiotherapy improve cancer outcome but at what cost?
New and very expensive forms of radiotherapy, such as intensity-modulated radiation therapy and proton therapy, have taken over the localized prostate cancer market. But is there enough evidence to justify the...
-
Article
Open AccessThe example of CaPSURE: lessons learned from a national disease registry
Although randomized controlled trials (RCTs) remain the gold standard for determining evidence-based clinical practices, large disease registries that enroll large numbers of patients have become paramount as ...
-
Chapter
Robot-Assisted Radical Prostatectomy: A Prostate Surgeon’s Perspective
The availability and promulgation of robotic technology has resulted in a paradigm shift for radical prostatectomy. Historically radical prostatectomy was performed using an open approach, usually the retropub...
-
Chapter
Quality of Care Indicators for Radical Cystectomy
Radical cystectomy is the gold standard treatment for invasive bladder cancer, and requires high standards for both surgical skill and ancillary support to achieve consistently good outcomes. As is the case el...
-
Article
High-risk prostate cancer in the United States, 1990–2007
This study aimed to describe national trends in presentation, management, and outcomes for men with high risk prostate cancer.
